PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Our fraught national debate over immunization and public health has overshadowed some extremely encouraging advances being made by researchers in the decades-long battle against cancer. Recent news of ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...

Pancreatic cancer ranks as one of the deadliest cancers worldwide, often remains silent early and becomes aggressive as it progresses. Globally, it makes up about 3% of all cancers, yet it causes many ...

Microscopic image of the pancreas organoid. The magenta shows the cell nuclei, and the cyan highlights the acinar cells that secrete digestive enzymes. Researchers from the Organoid group (previously ...